| NCT Number | NCT07228078 |
| Lead Sponsor | NKGen Biotech, Inc. |
| Conditions | Alzheimer Disease |
| Enrollment | 30 participants |
| Start Date | 2025-06-30 |
| Primary Completion | 2028-04 (estimated) |
| Study Completion | 2028-04 (estimated) |
| Updated on ClinicalTrials.gov | 2025-11-13 |